19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A glomerulus-on-a-chip to recapitulate the human glomerular filtration barrier

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In this work we model the glomerular filtration barrier, the structure responsible for filtering the blood and preventing the loss of proteins, using human podocytes and glomerular endothelial cells seeded into microfluidic chips. In long-term cultures, cells maintain their morphology, form capillary-like structures and express slit diaphragm proteins. This system recapitulates functions and structure of the glomerulus, including permselectivity. When exposed to sera from patients with anti-podocyte autoantibodies, the chips show albuminuria proportional to patients’ proteinuria, phenomenon not observed with sera from healthy controls or individuals with primary podocyte defects. We also show its applicability for renal disease modeling and drug testing. A total of 2000 independent chips were analyzed, supporting high reproducibility and validation of the system for high-throughput screening of therapeutic compounds. The study of the patho-physiology of the glomerulus and identification of therapeutic targets are also feasible using this chip.

          Abstract

          The glomerular filtration barrier is a complex structure in charge of renal ultrafiltration. Here the authors present a glomerulus-on-a-chip for disease modelling and high-throughput drug screening where human podocytes and human glomerular endothelial cells are separated by an extracellular matrix resembling the in vivo basement membrane.

          Related collections

          Most cited references47

          • Record: found
          • Abstract: found
          • Article: not found

          Pathophysiological advances in membranous nephropathy: time for a shift in patient's care.

          Membranous nephropathy is a major cause of nephrotic syndrome of non-diabetic origin in adults. It is the second or third leading cause of end-stage renal disease in patients with primary glomerulonephritis, and is the leading glomerulopathy that recurs after kidney transplantation (occurring in about 40% of patients). Treatment with costly and potentially toxic drugs remains controversial and challenging, partly because of insufficient insight into the pathogenesis of the disease and absence of sensitive biomarkers of disease activity. The disease is caused by the formation of immune deposits on the outer aspect of the glomerular basement membrane, which contain podocyte or planted antigens and circulating antibodies specific to those antigens, resulting in complement activation. In 2002, podocyte neutral endopeptidase was identified as an antigenic target of circulating antibodies in alloimmune neonatal nephropathy, and in 2009, podocyte phospholipase A2 receptor (PLA2R) was reported as an antigenic target in autoimmune adult membranous nephropathy. These major breakthroughs were translated to clinical practice very quickly. Measurement of anti-PLA2R antibodies in serum and detection of PLA2R antigen in glomerular deposits can now be done routinely. Anti-PLA2R antibodies have high specificity (close to 100%), sensitivity (70-80%), and predictive value. PLA2R detection in immune deposits allows for retrospective diagnosis of PLA2R-related membranous nephropathy in archival kidney biopsies. These tests already have a major effect on diagnosis and monitoring of treatment, including after transplantation.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The mesangial cell revisited: no cell is an island.

            Mesangial cells and their matrix form the central stalk of the glomerulus and are part of a functional unit interacting closely with endothelial cells and podocytes. Alterations in one cell type can produce changes in the others. The cytokines generated by mesangial cells, endothelial cells, and podocytes that tridirectionally and interactively influence cognate receptors on receiver cells are not fully defined. The existence of cytokine cross-talk seems very likely, given the observations that podocyte injury frequently results in mesangial cell proliferation, whereas mesangial cell injury leads to foot process fusion and proteinuria. Another potentially fruitful area of future research is the role of mesangial cells as local modulators of innate and adaptive immune responses. Thus, mesangial cell research still holds much promise.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              The cell biology of renal filtration

              The function of the kidney, filtering blood and concentrating metabolic waste into urine, takes place in an intricate and functionally elegant structure called the renal glomerulus. Normal glomerular function retains circulating cells and valuable macromolecular components of plasma in blood, resulting in urine with just trace amounts of proteins. Endothelial cells of glomerular capillaries, the podocytes wrapped around them, and the fused extracellular matrix these cells form altogether comprise the glomerular filtration barrier, a dynamic and highly selective filter that sieves on the basis of molecular size and electrical charge. Current understanding of the structural organization and the cellular and molecular basis of renal filtration draws from studies of human glomerular diseases and animal models of glomerular dysfunction.
                Bookmark

                Author and article information

                Contributors
                lperin@chla.usc.edu
                sdasacco@chla.usc.edu
                Journal
                Nat Commun
                Nat Commun
                Nature Communications
                Nature Publishing Group UK (London )
                2041-1723
                13 August 2019
                13 August 2019
                2019
                : 10
                : 3656
                Affiliations
                [1 ]ISNI 0000 0001 2153 6013, GRID grid.239546.f, GOFARR Laboratory for Organ Regenerative Research and Cell Therapeutics in Urology, Saban Research Institute, Division of Urology, , Children’s Hospital Los Angeles, ; Los Angeles, CA USA
                [2 ]ISNI 0000 0001 0670 2351, GRID grid.59734.3c, Division of Nephrology, , Icahn School of Medicine at Mount Sinai, ; New York, NY USA
                [3 ]ISNI 0000 0004 1757 1758, GRID grid.6292.f, Department of Experimental, Diagnostic and Specialty Medicine, Nephrology, Dialysis and Renal Transplant Unit, S. Orsola-Malpighi Hospital, , University of Bologna, ; Bologna, Italy
                [4 ]GRID grid.497559.3, Nephrology Service, , Complejo Hospitalario de Navarra, ; Pamplona, Spain
                [5 ]ISNI 0000 0004 1759 0844, GRID grid.411477.0, Genetica Medica, , Azienda Ospedaliera Universitaria Senese, ; Siena, Italy
                [6 ]ISNI 0000 0001 2156 6853, GRID grid.42505.36, Department of Urology, Keck School of Medicine, , University of Southern California, ; Los Angeles, CA USA
                Author information
                http://orcid.org/0000-0002-6121-5326
                http://orcid.org/0000-0002-0846-9220
                http://orcid.org/0000-0001-9654-6822
                Article
                11577
                10.1038/s41467-019-11577-z
                6692336
                31409793
                5cb13648-b506-4904-8e58-0a5a48c68b55
                © The Author(s) 2019

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 10 November 2018
                : 23 July 2019
                Funding
                Funded by: GOFARR Kidney Fund
                Funded by: Wright Foundation GOFARR Kidney Fund Alport Syndrome Foundation TSRI Research Career Development Award
                Categories
                Article
                Custom metadata
                © The Author(s) 2019

                Uncategorized
                lab-on-a-chip,glomerulus
                Uncategorized
                lab-on-a-chip, glomerulus

                Comments

                Comment on this article